Furthermore, their results provide evidence that ccRCC patients with the PTEN mutation are more susceptible to distant metastasis, indicating that early intervention is necessary for patients to have a longer survival [104]. This evidence concerns the gene PTEN and nonpapillary renal cell carcinoma.